Main Research Findings

1) Treatment with IPAM was found to reverse age-related mitochondrial decline and increase rotifer lifespan, and improve rotifer reproductive activity.

Selected Data
1) The study conducted by Poeggeler et al investigated the biological effects of indolepropionamide (IPAM), an endogenous indole compound structurally related to melatonin and derived from indole-3-propionic acid (IPA). The researchers used a series of complementary experiments to determine whether IPAM could protect mitochondria from age-related and chemically induced dysfunction, reduce oxidative damage, and extend lifespan. The experimental design included chemical synthesis and identification of IPAM, analysis of its presence and availability in the brain, assessment of mitochondrial membrane potential and respiratory-chain activity, evaluation of antioxidant properties, and lifespan testing in the bdelloid rotifer Philodina acuticornis odiosa. Melatonin and IPA were used as comparison compounds in several experiments to determine whether IPAM demonstrated distinct or enhanced biological activity [1].
The investigators first synthesized IPAM so that a purified reference compound would be available for biochemical and analytical experiments. IPAM was generated from indole-3-propionic acid through a multistep chemical procedure involving conversion of the acid to its ethyl ester, formation of a propanoic acid hydrazide intermediate, and subsequent chemical reduction. The final product was purified chromatographically and obtained at a high yield. The researchers then examined whether IPAM was naturally present in biological tissue. Rat brain samples were analyzed using high-performance liquid chromatography with fluorometric detection. Because endogenous IPAM was present at very low concentrations, young male Sprague-Dawley rats were administered 300 mg/kg of L-tryptophan, a precursor involved in indole metabolism. Brain tissue was collected approximately one hour later and analyzed for IPAM, melatonin, and IPA. Synthetic standards were analyzed alongside the biological samples to confirm the identity of the detected compounds by comparing chromatographic retention times.
The researchers next evaluated the ability of IPAM to reach the brain following systemic administration. One-month-old male Sprague-Dawley rats received intraperitoneal injections of IPAM, melatonin, or IPA at 0.5 mg/kg. Brain samples were collected at two, four, and eight hours following administration, and compound concentrations were measured. This experiment allowed the investigators to compare the persistence and central availability of IPAM with those of its structurally related compounds. The study then examined mitochondrial function using mitochondria isolated from the brains of young and aged animals. Mitochondrial membrane potential was measured using rhodamine 123 fluorescence. Mitochondria were supplied with malate and glutamate to stimulate respiration, and changes in fluorescence were used to determine mitochondrial membrane potential. Preparations from young and aged animals were treated with 10 nM IPAM, melatonin, or IPA to determine whether these compounds could improve mitochondrial energetic function [1].
To further examine mitochondrial protection, isolated mitochondria were exposed to three pharmacological stressors: doxorubicin, antimycin A, and FCCP. Each compound was used to disrupt mitochondrial function and decrease membrane potential. IPAM was then added to determine whether it could prevent or attenuate mitochondrial depolarization. The investigators also examined the effects of IPAM on mitochondrial respiratory-chain activity. Activities of respiratory complexes I and IV were measured in mitochondrial preparations, while complex I activity was independently assessed using an NBT reduction assay. This additional experiment focused on the N2 iron-sulfur center of complex I and provided an independent measurement of complex I activity. Appropriate inhibitor controls were used to verify the specificity of the assay [1].
The antioxidant properties of IPAM were assessed using chemical systems capable of generating hydroxyl radicals. The investigators used a mixture containing hydrogen peroxide, ferric chloride, and EDTA to generate oxidative species and measured hydroxyl-radical production through HPLC analysis of salicylate oxidation products. Additional experiments used rat forebrain homogenates exposed to hydrogen peroxide, ferrous sulfate, and ADP to produce oxidative stress. The extent of oxidative DNA damage was determined by measuring 8-hydroxydeoxyguanosine, a marker of DNA oxidation. Different concentrations of IPAM and comparison compounds were tested to establish concentration-response relationships and determine their relative antioxidant potency. The researchers also assessed whether IPAM demonstrated pro-oxidant activity under the experimental conditions.
The final component of the study examined whether IPAM could influence organismal lifespan using the bdelloid rotifer Philodina acuticornis odiosa. Individual rotifers were maintained under controlled laboratory conditions and exposed to IPAM at concentrations of 10, 20, or 30 μM. Untreated animals served as controls. Survival was monitored throughout the experiment to determine whether IPAM produced a concentration-dependent extension of lifespan. In addition to survival, the investigators measured body size, offspring production, and reproductive lifespan. These additional measures were used to determine whether an extension of chronological lifespan was accompanied by changes in growth or reproductive capacity. The combination of mitochondrial experiments in rodents and lifespan experiments in rotifers allowed the researchers to examine IPAM at both the cellular and organismal levels [[1].
Overall, the methodology was designed to determine whether IPAM could influence several interconnected processes involved in aging, particularly mitochondrial dysfunction and oxidative stress. The experiments progressed from chemical identification and brain availability to isolated mitochondrial preparations, oxidative-damage assays, and whole-organism longevity testing. This multi-level approach allowed the investigators to determine whether the compound’s effects extended beyond antioxidant activity and involved direct effects on mitochondrial energy metabolism. The use of both young and aged mitochondrial preparations also allowed the researchers to evaluate whether IPAM could counteract age-associated declines in mitochondrial function. Comparison with melatonin and IPA provided additional context for determining whether the biological effects of IPAM were distinctive among related indole compounds [1].

Discussion
1) The results of the study performed by Poeggeler et al demonstrated that indolepropionamide (IPAM) possesses several biological properties that may contribute to mitochondrial protection and longevity. The investigators first established that IPAM could be detected as an endogenous compound in the brain and subsequently demonstrated that the molecule had substantially greater brain availability than the structurally related compounds melatonin and indole-3-propionic acid (IPA). The study then showed that IPAM could preserve mitochondrial membrane potential in aging brain mitochondria, protect mitochondria from several pharmacological toxins, increase the activity of specific components of the mitochondrial electron-transport chain, and reduce hydroxyl-radical-mediated oxidative damage. Finally, experiments in the bdelloid rotifer Philodina acuticornis odiosa demonstrated that IPAM produced a striking extension of lifespan while also increasing organism size, reproductive output, and the duration of reproductive activity. Together, these findings supported the authors’ hypothesis that IPAM may function as an endogenous regulator of mitochondrial energy metabolism and oxidative stress [1].
The first major finding was that IPAM occurs naturally in rat brain tissue. Direct analysis of untreated brain samples suggested that endogenous IPAM was present only at very low concentrations, making precise quantification difficult. To increase the amount of detectable compound, the investigators administered L-tryptophan to young rats because tryptophan serves as a precursor for several biologically active indole compounds. One hour after administration of 300 mg/kg L-tryptophan, IPAM, melatonin, and IPA could all be detected in the brain. The measured concentrations were approximately 34,669 pg indole/mg protein for IPAM, 713,632 pg/mg protein for melatonin, and 281,614 pg/mg protein for IPA. Importantly, the chromatographic peak corresponding to endogenous IPAM occurred at the same retention time as the synthetic IPAM standard. Additional samples containing synthetic standards demonstrated corresponding peaks, strengthening the identification of the endogenous compound. These results indicated that IPAM is not merely a synthetic derivative created for experimental purposes but can occur naturally within the brain and can be influenced by tryptophan availability [1].
The researchers next compared the brain bioavailability of IPAM, melatonin, and IPA after systemic administration. Young male Sprague-Dawley rats received 0.5 mg/kg of each compound intraperitoneally, and brain samples were collected two, four, and eight hours later. Melatonin and IPA remained at barely detectable concentrations and did not demonstrate a substantial increase over baseline. IPAM, in contrast, produced markedly higher concentrations within the brain. At two hours, brain IPAM concentrations reached approximately 691 ± 23 pg/mg protein. Concentrations remained high at four hours, measuring approximately 562 ± 13 pg/mg protein, and were still detectable at eight hours at approximately 361 ± 12 pg/mg protein. The continued presence of IPAM demonstrated that the compound could enter the brain and remain available for several hours after administration.
The authors attributed the improved brain availability of IPAM, at least partly, to its chemical structure. IPA contains a carboxylic-acid group that becomes negatively charged under physiological conditions, limiting its ability to pass through biological membranes. IPAM instead contains an amide group and possesses greater lipophilic and amphiphilic characteristics. This structural difference may facilitate movement through cellular membranes and contribute to the greater brain concentrations observed experimentally. The results were therefore consistent with the investigators’ original rationale for developing IPAM from IPA: modifying the parent molecule could preserve beneficial indole-related activity while improving biological availability. The relatively prolonged presence of IPAM in brain tissue also provided an important basis for examining its potential effects on neuronal mitochondria and oxidative processes [1]
The mitochondrial experiments revealed a clear age-related decline in mitochondrial energetic function. Brain mitochondria isolated from older animals demonstrated a pronounced reduction in proton motive force and mitochondrial membrane potential compared with preparations obtained from younger animals. Because the mitochondrial membrane potential is essential for oxidative phosphorylation and ATP synthesis, this decline represented an important indicator of age-associated mitochondrial dysfunction. Treatment with IPAM, melatonin, or IPA opposed this age-related reduction in mitochondrial membrane potential. Although all three indoles demonstrated protective activity, IPAM produced a particularly strong effect. The investigators therefore concluded that IPAM could counteract the deterioration in mitochondrial energetic capacity that accompanies aging. These results were particularly important because the compound produced its effects at a concentration of only 10 nM, suggesting substantial activity in the experimental mitochondrial system.
IPAM’s protective effects became even more apparent when mitochondria were exposed to specific pharmacological stressors. The investigators used doxorubicin, antimycin A, and FCCP, which disrupt mitochondrial function through different mechanisms. Doxorubicin and antimycin A interfere with mitochondrial electron transport, whereas FCCP dissipates the proton gradient across the mitochondrial membrane. All three agents produced significant mitochondrial depolarization, demonstrating a substantial collapse in mitochondrial proton potential. When IPAM was added, however, the loss of membrane potential was markedly reduced. The protective effect was observed in mitochondrial preparations from both young and old animals. IPAM reduced toxin-induced mitochondrial depolarization toward near-baseline levels, demonstrating that its effects were not restricted to untreated mitochondria. Instead, the compound could also preserve mitochondrial function when the organelles were subjected to substantial pharmacological stress [1].
The researchers then investigated whether these effects were related to direct changes in the mitochondrial respiratory chain. IPAM increased the activity of mitochondrial complex I and complex IV, while melatonin produced smaller effects. The increase in complex I activity was confirmed using a second experimental approach based on measurement of the N2 iron-sulfur cluster through an NBT reduction assay. This independent measurement reproduced the evidence for increased complex I activity. In contrast, the researchers reported no significant change in complex II–III activity. The investigators also observed displacement of known ligands from mitochondrial binding sites, supporting the possibility that IPAM interacts directly with mitochondrial components. These findings suggested that IPAM may influence mitochondrial energy production by interacting with the respiratory chain rather than functioning solely as a nonspecific antioxidant. In particular, the effect on complex I was considered important because this complex represents a major component of oxidative phosphorylation and is also an important site associated with electron leakage and ROS generation.

Figure 1: Changes in N2 cluster, complex I, and complex IV activity following treatment with IPAM.
The antioxidant experiments provided additional evidence for IPAM’s protective properties. When the investigators used a chemical system capable of generating hydroxyl radicals, IPAM demonstrated the strongest antioxidant activity among the compounds tested. Importantly, IPAM did not produce detectable pro-oxidant intermediates under the experimental conditions. This was significant because some indole compounds that exhibit antioxidant activity can simultaneously generate secondary reactive species, potentially reducing their overall protective effects. IPA also lacked detectable pro-oxidant activity, whereas serotonin, 6-hydroxymelatonin, and 5-methoxyindoleacetic acid increased hydroxyl-radical formation and therefore displayed pro-oxidant behavior in the assay. IPAM’s ability to suppress hydroxyl radicals without generating additional detectable oxidative intermediates distinguished it from several related compounds [1].
The investigators also determined how effectively IPAM prevented oxidative DNA damage in rat forebrain homogenates. IPAM reduced hydroxyl-radical-mediated DNA injury and inhibited formation of 8-hydroxydeoxyguanosine, a marker of oxidative damage to DNA. The IC50 for IPAM was approximately 0.18 ± 0.03 mM, compared with 1.46 ± 0.16 mM for melatonin and 7.46 ± 0.80 mM for IPA. Therefore, IPAM required a considerably lower concentration than either melatonin or IPA to produce a 50% reduction in oxidative DNA damage under the conditions of the experiment. This result further supported the conclusion that IPAM has strong antioxidant activity. The investigators interpreted the findings as evidence that IPAM could protect biological macromolecules from free-radical-mediated injury while avoiding the pro-oxidant activity demonstrated by several other related indoles.
The study then extended the investigation from isolated mitochondria to an organismal model of aging. The bdelloid rotifer Philodina acuticornis odiosa was treated with IPAM at concentrations of 10, 20, or 30 μM. All three concentrations produced significant and concentration-dependent increases in lifespan. Control rotifers had a mean lifespan of approximately 24.6 ± 1.8 days. Treatment with 10 μM IPAM increased mean lifespan to 58.5 ± 3.3 days, while 20 μM increased lifespan to 81.1 ± 3.7 days. At the highest concentration, 30 μM IPAM increased mean lifespan to 90.5 ± 3.8 days. Thus, the highest dose produced an increase in average lifespan exceeding 300% relative to controls. The authors described this as an exceptionally large lifespan extension for this experimental model [1].
Interestingly, the longevity effect was accompanied by evidence of enhanced growth rather than reduced physiological activity. After 15 days of treatment with 30 μM IPAM, treated rotifers were visibly larger than age-matched control animals. Average rotifer length increased from approximately 390 ± 5 μm in control animals to 575 ± 6 μm in IPAM-treated animals. This represented a substantial increase in body size. The observation was notable because some interventions that extend lifespan can produce tradeoffs involving slower growth or reduced reproduction. In this experiment, however, IPAM-treated rotifers appeared to maintain or improve developmental characteristics while living substantially longer. The authors therefore suggested that IPAM may have a growth-promoting effect in addition to its longevity-associated activity.
IPAM also produced substantial effects on reproductive performance. Control rotifers produced an average of approximately 16 ± 1 offspring during their lifetime, whereas animals treated daily with 30 μM IPAM produced approximately 55 ± 1 offspring. Lower concentrations were similarly effective, with 10 and 20 μM IPAM producing averages of approximately 52 and 53 offspring, respectively. Therefore, IPAM treatment increased total reproductive output at every concentration examined. The reproductive period was also prolonged. Control rotifers remained fertile for approximately 5 ± 1 days, whereas 30 μM IPAM extended the reproductive period to approximately 18 ± 1 days. The 10 and 20 μM treatments extended reproductive activity to approximately 13 and 16 days, respectively. The effects on both growth and fertility were statistically significant [1]..
Overall, the results demonstrated that IPAM affected multiple biological processes related to mitochondrial function, oxidative stress, and aging. The compound was identified in rat brain tissue, demonstrated substantially greater brain persistence than melatonin and IPA, and improved mitochondrial membrane potential in both young and aged preparations. IPAM also protected mitochondria against several different toxic challenges and increased the activity of respiratory-chain complexes I and IV. Its antioxidant activity was demonstrated by reduced hydroxyl-radical formation and decreased oxidative DNA damage, with IPAM showing greater potency than melatonin and IPA in the DNA-damage assay. At the organismal level, IPAM produced a striking extension of rotifer lifespan while simultaneously increasing body size, offspring production, and reproductive duration [1].

Disclaimer

**LAB USE ONLY**
*This information is for educational purposes only and does not constitute medical advice. THE PRODUCTS DESCRIBED HEREIN ARE FOR RESEARCH USE ONLY. All clinical research must be conducted with oversight from the appropriate Institutional Review Board (IRB). All preclinical research must be conducted with oversight from the appropriate Institutional Animal Care and Use Committee (IACUC) following the guidelines of the Animal Welfare Act (AWA).

Citations

[1] Poeggeler B, Sambamurti K, Siedlak SL, Perry G, Smith MA, Pappolla MA. A novel endogenous indole protects rodent mitochondria and extends rotifer lifespan. PLoS One. 2010;5(4):e10206. Published 2010 Apr 21. doi:10.1371/journal.pone.0010206

Indolepropionamide (IPAM) is sold for laboratory research use only. Terms of sale apply. Not for human consumption, nor medical, veterinary, or household uses. Please familiarize yourself with our Terms & Conditions prior to ordering.